Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,294.50 -12.67 -0.08%
S&P 500 1,650.51 -4.84 -0.29%
Nasdaq 3,459.42 -3.88 -0.11%
Ticker Volume Price Price Delta
STOXX 50 2,776.78 -58.23 -2.05%
FTSE 100 6,696.79 -143.48 -2.10%
DAX 8,351.98 -178.91 -2.10%
Ticker Volume Price Price Delta
Nikkei 14,484.00 -1,143.28 -7.32%
Hang Seng 22,669.70 -591.40 -2.54%
S&P/ASX 200 5,062.45 -102.92 -1.99%
  • Exchange: ASE
  • Sector: Consumer, Non-cyclical
  • Industry: Healthcare-Products
  • Sub-Industry: Medical Products

Cochlear Ltd

+ Add to Watchlist

COH:AU

67.1200 AUD 1.9000 2.75%

As of 02:10:09 ET on 05/23/2013.

Company Profile for Cochlear Ltd (COH)

Cochlear Limited researches, develops and markets cochlear implant systems for hearing impaired individuals. The Company's hearing implant systems include Nucleus and Baha and are sold both domestically and internationally.

Contact Information

Cochlear Ltd

14 Mars Road
Lane Cove, NSW 2066
Australia
Phone: 61-2-9428-6555
Fax: 61-2-9428-6353

Key Executives for Cochlear Ltd (COH)

Christopher Graham Roberts "Chris"President/CEONeville J MitchellCFO/Secretary
Richard BrookPres:EuropeanMark SalmonPres:Asia Pacific
Christopher M Smith "Chris"Pres:AmericasJan JanssenSenior VP:Design & Development

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil